Form 4: Xometry Director Emily Rollins Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Emily Rollins, a director at Xometry, Inc., sold a portion of her Class A Common Stock holdings on November 7, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On November 7, 2024, Emily Rollins, a director of Xometry, Inc., executed sales of Class A Common Stock.
- The sales were conducted under a pre-arranged Rule 10b5-1 trading plan.
- A total of 3,105 shares were sold at a weighted average price of $29.3649, with individual prices ranging from $28.94 to $29.795.
- An additional 624 shares were sold at a weighted average price of $30.1095, with individual prices ranging from $29.97 to $30.275.
- Following these transactions, Rollins' direct ownership stands at 12,457 shares.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating stock sales by a company director under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment about the company's prospects.
Industry Context
Sales by company directors are a common occurrence and are often related to personal financial planning rather than a reflection of the company's performance. The use of a 10b5-1 trading plan allows insiders to sell shares over a period of time without being accused of trading on non-public information.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders due to the increased supply of shares in the market.
Key Dates
| Date | Description |
|---|---|
| 11/07/2024 | Date of stock sale transactions. |
| 11/12/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.